News SCOTUS retains telemedicine access to abortion pill The Supreme Court of the US has ruled that abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order – for now.
News NICE backs stomach cancer, PAH drugs for NHS use AZ's Imfinzi is the first NHS immunotherapy for a form of stomach cancer, while MSD's Winrevair gets a green light for rare respiratory disease PAH.
News Anthropic joins Gates Foundation on $200m health AI pledge Anthropic and the Gates Foundation's initiative will close a gap in access to AI tools between high- and lower-income countries.
News Trial miss doesn't dent Biogen's faith in Alzheimer's drug Biogen will advance its tau-targeting Alzheimer's disease drug diranersen into phase 3, even though it missed the main endpoint in a midstage trial.
News UK Health Secretary resigns, sparking leadership speculation UK Health Secretary Wes Streeting has resigned from Keir Starmer's government, saying he has lost faith in the Prime Minister's leadership.
News Regenxbio's Duchenne gene therapy clears phase 3 hurdle Regenxbio is pitching at FDA approval in 2027 for its Duchenne muscular dystrophy gene therapy RGX-202, a potential rival to Sarepta/Roche's Elevidys.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.